Among the key players in tumour immunology, Traditionally, CD4+ T-cells have been acknowledged for their role as helper cells that support cytotoxic CD8+ T-cell responses and B-cell activation (Alberts et al., 2002; Bevan, 2004). The gene discussed is CD4; the disease is neoplasm.